8-K
filed December 29, 2022, 6:59 PM ET
ticker ESLA
CIK 0001844417
other material
confidence high
sentiment neutral
materiality 0.60
TradeUP Acquisition Corp. stockholders approve extension of business combination deadline to July 19, 2023
Estrella Immunopharma, Inc.
- Extension Proposal approved (4,380,625 for, 500 against): extends deadline from Jan 19 to Jul 19, 2023.
- Trust Amendment Proposal approved (4,379,446 for, 1,678 against) to extend liquidation date accordingly.
- Weston Twigg re-elected Class I director with 4,044,959 for, 336,166 withheld.
- Marcum LLP ratified as independent auditor for FY2022: 4,353,040 for, 500 against, 27,585 abstain.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Estrella Immunopharma, Inc. shareholders approved The Extension Proposal The stockholders approved the proposal to amend the Company’s amended and restated certificate of incorporation to extend the date before which the Company must complete a business combination from January 19, 2023 to July 19, 2023 or such earlier date as determined by the boa at the 2022-12-22 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2022-12-22
Exact text from the filing
On December 22, 2022, TradeUP Acquisition Corp. (the “Company”) held a special meeting in lieu of its 2022 annual meeting of stockholders (the “Special Meeting”). On November 30, 2022, the record date for the Special Meeting, there were 5,849,700 shares of common stock of the Company entitled to be voted at the Special Meeting, approximately 74.89% of which were represented in person or by proxy at the special meeting. The final results for each of the matters submitted to a vote of the Company’s stockholders at the special meeting are as follows: 1. The Extension Proposal The stockholders approved the proposal to amend the Company’s amended and restated certificate of incorporation to extend the date before which the Company must complete a business combination from January 19, 2023 to July 19, 2023 or such earlier date as determined by the board of directors of the Company (such extension is herein referred to as the “Extension”), and provide that the date for cessation of operations
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Estrella Immunopharma, Inc. shareholders approved The Director Election Proposal The stockholders re-elected Mr. Weston Twigg as Class I director of the Company to serve three-year term till the 2025 annual meeting of stockholders or until his successor is elected and qualified. at the 2022-12-22 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-12-22
Exact text from the filing
On December 22, 2022, TradeUP Acquisition Corp. (the “Company”) held a special meeting in lieu of its 2022 annual meeting of stockholders (the “Special Meeting”). On November 30, 2022, the record date for the Special Meeting, there were 5,849,700 shares of common stock of the Company entitled to be voted at the Special Meeting, approximately 74.89% of which were represented in person or by proxy at the special meeting. The final results for each of the matters submitted to a vote of the Company’s stockholders at the special meeting are as follows: 1. The Extension Proposal The stockholders approved the proposal to amend the Company’s amended and restated certificate of incorporation to extend the date before which the Company must complete a business combination from January 19, 2023 to July 19, 2023 or such earlier date as determined by the board of directors of the Company (such extension is herein referred to as the “Extension”), and provide that the date for cessation of operations
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Estrella Immunopharma, Inc. shareholders approved The Trust Amendment Proposal The stockholders approved the proposal to amend the Investment Management Trust Agreement, dated July 14, 2021, by and between the Company and Wilmington Trust, National Association, acting as trustee, to extend the liquidation date from January 19, 2023 to July 19, 2023 at the 2022-12-22 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2022-12-22
Exact text from the filing
On December 22, 2022, TradeUP Acquisition Corp. (the “Company”) held a special meeting in lieu of its 2022 annual meeting of stockholders (the “Special Meeting”). On November 30, 2022, the record date for the Special Meeting, there were 5,849,700 shares of common stock of the Company entitled to be voted at the Special Meeting, approximately 74.89% of which were represented in person or by proxy at the special meeting. The final results for each of the matters submitted to a vote of the Company’s stockholders at the special meeting are as follows: 1. The Extension Proposal The stockholders approved the proposal to amend the Company’s amended and restated certificate of incorporation to extend the date before which the Company must complete a business combination from January 19, 2023 to July 19, 2023 or such earlier date as determined by the board of directors of the Company (such extension is herein referred to as the “Extension”), and provide that the date for cessation of operations
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Estrella Immunopharma, Inc. shareholders approved The Auditor Appointment Proposal The stockholders ratified the engagement of Marcum LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. at the 2022-12-22 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-12-22
Exact text from the filing
On December 22, 2022, TradeUP Acquisition Corp. (the “Company”) held a special meeting in lieu of its 2022 annual meeting of stockholders (the “Special Meeting”). On November 30, 2022, the record date for the Special Meeting, there were 5,849,700 shares of common stock of the Company entitled to be voted at the Special Meeting, approximately 74.89% of which were represented in person or by proxy at the special meeting. The final results for each of the matters submitted to a vote of the Company’s stockholders at the special meeting are as follows: 1. The Extension Proposal The stockholders approved the proposal to amend the Company’s amended and restated certificate of incorporation to extend the date before which the Company must complete a business combination from January 19, 2023 to July 19, 2023 or such earlier date as determined by the board of directors of the Company (such extension is herein referred to as the “Extension”), and provide that the date for cessation of operations
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.